F. Hoffmann-La Roche Ltd: Roche reports strong 2024 results with 7% sales growth; fourth quarter marks third straight quarter of 9% growth
Group sales grew by 7%1 at constant exchange rates (CER; 3% in CHF), driven by strong demand for both medicines and diagnostics.Excluding COVID-19, Group sales increased by 9%.
Inhalation of xenon gas shows promise as a neuroprotective treatment for Alzheimer's Disease
Xenon gas, currently used in medicine as an anesthetic and neuroprotective agent for treating brain injuries, showed ...